STOPP/START interventions to improve medicines management for people aged 65 years and over: a realist synthesis

Background: Drug-related problems and potentially inappropriate prescribing impose a huge burden on patients and the health-care system. The most widely used tools for appropriate prescription in older adults in England and in other European countries are the Screening Tool of Older People’s Prescri...

Full description

Bibliographic Details
Main Authors: Jaheeda Gangannagaripalli, Ian Porter, Antoinette Davey, Ignacio Ricci Cabello, Joanne Greenhalgh, Rob Anderson, Simon Briscoe, Carmel Hughes, Rupert Payne, Emma Cockcroft, Jim Harris, Charlotte Bramwell, Jose M Valderas
Format: Article
Language:English
Published: National Institute for Health Research 2021-11-01
Series:Health Services and Delivery Research
Subjects:
Online Access:https://doi.org/10.3310/hsdr09230
_version_ 1818279737648218112
author Jaheeda Gangannagaripalli
Ian Porter
Antoinette Davey
Ignacio Ricci Cabello
Joanne Greenhalgh
Rob Anderson
Simon Briscoe
Carmel Hughes
Rupert Payne
Emma Cockcroft
Jim Harris
Charlotte Bramwell
Jose M Valderas
author_facet Jaheeda Gangannagaripalli
Ian Porter
Antoinette Davey
Ignacio Ricci Cabello
Joanne Greenhalgh
Rob Anderson
Simon Briscoe
Carmel Hughes
Rupert Payne
Emma Cockcroft
Jim Harris
Charlotte Bramwell
Jose M Valderas
author_sort Jaheeda Gangannagaripalli
collection DOAJ
description Background: Drug-related problems and potentially inappropriate prescribing impose a huge burden on patients and the health-care system. The most widely used tools for appropriate prescription in older adults in England and in other European countries are the Screening Tool of Older People’s Prescriptions (STOPP)/Screening Tool to Alert to the Right Treatment (START) tools. STOPP/START tools support medicines optimisation for older adults. Objectives: To identify, test and refine the programme theories underlying how interventions based on the STOPP/START tools are intended to work, for whom, in what circumstances and why, as well as the resource use and cost requirements or impacts. Design: A realist synthesis. Setting: Primary care, hospital care and nursing homes. Patients: Patients aged ≥ 65 years. Interventions: Any intervention based on the use of the STOPP/START tools. Review methods: Database and web-searching was carried out to retrieve relevant evidence to identify and test programme theories about how interventions based on the use of the STOPP/START tools work. A project reference group made up of health-care professionals, NHS decision-makers, older people, carers and members of the public was set up. In phase 1 we identified programme theories about STOPP/START interventions on how, for whom, in what contexts and why they are intended to work. We searched the peer-reviewed and grey literature to identify documents relevant to the research questions. We interviewed experts in the field in our reference group to gain input on our list of candidate context–mechanism–outcome configurations, to identify additional context–mechanism–outcome configurations and to identify additional literature and/or relevant concepts. In phase 2 we reviewed and synthesised relevant published and unpublished empirical evidence and tested the programme theories using evidence from a larger set of empirical studies. Results: We developed a single logic model structured around three key mechanisms: (1) personalisation, (2) systematisation and (3) evidence implementation. Personalisation: STOPP/START-based interventions are based on shared decision-making, taking into account patient preferences, experiences and expectations (mechanisms), leading to increased patient awareness, adherence, satisfaction, empowerment and quality of life (outcomes). Systematisation: STOPP/START tools provide a standardised/systematic approach for medication reviews (mechanisms), leading to changes in professional and organisational culture and burden/costs (outcomes). Evidence implementation: delivery of STOPP/START-based interventions is based on the implementation of best evidence (mechanisms), reducing adverse outcomes through appropriate prescribing/deprescribing (outcomes). For theory testing, we identified 40 studies of the impact of STOPP/START-based interventions in hospital settings, nursing homes, primary care and community pharmacies. Most of the interventions used multiple mechanisms. We found support for the impact of the personalisation and evidence implementation mechanisms on selected outcome variables, but similar impact was achieved by interventions not relying on these mechanisms. We also observed that the impact of interventions was linked to the proximity of the selected outcomes to the intervention in the logic model, resulting in a clearer benefit for appropriateness of prescribing, adverse drug events and prescription costs. Limitations: None of the available studies had been explicitly designed for evaluating underlying causal mechanisms, and qualitative information was sparse. Conclusions: No particular configuration of the interventions is associated with a greater likelihood of improved outcomes in given settings. Study registration: This study is registered as PROSPERO CRD42018110795. Funding: This project was funded by the National Institute for Health Research (NIHR) Health Services and Delivery Research programme and will be published in full in Health Services and Delivery Research; Vol. 9, No. 23. See the NIHR Journals Library website for further project information.
first_indexed 2024-12-12T23:38:05Z
format Article
id doaj.art-6a59de15b4214298abfb9f79add528b5
institution Directory Open Access Journal
issn 2050-4349
2050-4357
language English
last_indexed 2024-12-12T23:38:05Z
publishDate 2021-11-01
publisher National Institute for Health Research
record_format Article
series Health Services and Delivery Research
spelling doaj.art-6a59de15b4214298abfb9f79add528b52022-12-22T00:07:19ZengNational Institute for Health ResearchHealth Services and Delivery Research2050-43492050-43572021-11-0192310.3310/hsdr0923017/100/13STOPP/START interventions to improve medicines management for people aged 65 years and over: a realist synthesisJaheeda Gangannagaripalli0Ian Porter1Antoinette Davey2Ignacio Ricci Cabello3Joanne Greenhalgh4Rob Anderson5Simon Briscoe6Carmel Hughes7Rupert Payne8Emma Cockcroft9Jim Harris10Charlotte Bramwell11Jose M Valderas12Health Services and Policy Research Group, University of Exeter Medical School, Exeter, UKHealth Services and Policy Research Group, University of Exeter Medical School, Exeter, UKHealth Services and Policy Research Group, University of Exeter Medical School, Exeter, UKGerència d’Atenció Primària de Mallorca, Fundació Institut d’Investigació Sanitària Illes Balears – IdISBa, Mallorca, SpainSchool of Sociology and Social Policy, University of Leeds, Leeds, UKHealth Services and Policy Research Group, University of Exeter Medical School, Exeter, UKHealth Services and Policy Research Group, University of Exeter Medical School, Exeter, UKSchool of Pharmacy, Queen’s University Belfast, Belfast, UKPopulation Health Sciences, University of Bristol, Bristol Medical School, Bristol, UKNational Institute for Health Research Collaboration for Leadership in Applied Health Research and Care for the South West Peninsula, University of Exeter Medical School, Exeter, UKHealth Services and Policy Research Group, University of Exeter Medical School, Exeter, UKHealth Services and Policy Research Group, University of Exeter Medical School, Exeter, UKHealth Services and Policy Research Group, University of Exeter Medical School, Exeter, UKBackground: Drug-related problems and potentially inappropriate prescribing impose a huge burden on patients and the health-care system. The most widely used tools for appropriate prescription in older adults in England and in other European countries are the Screening Tool of Older People’s Prescriptions (STOPP)/Screening Tool to Alert to the Right Treatment (START) tools. STOPP/START tools support medicines optimisation for older adults. Objectives: To identify, test and refine the programme theories underlying how interventions based on the STOPP/START tools are intended to work, for whom, in what circumstances and why, as well as the resource use and cost requirements or impacts. Design: A realist synthesis. Setting: Primary care, hospital care and nursing homes. Patients: Patients aged ≥ 65 years. Interventions: Any intervention based on the use of the STOPP/START tools. Review methods: Database and web-searching was carried out to retrieve relevant evidence to identify and test programme theories about how interventions based on the use of the STOPP/START tools work. A project reference group made up of health-care professionals, NHS decision-makers, older people, carers and members of the public was set up. In phase 1 we identified programme theories about STOPP/START interventions on how, for whom, in what contexts and why they are intended to work. We searched the peer-reviewed and grey literature to identify documents relevant to the research questions. We interviewed experts in the field in our reference group to gain input on our list of candidate context–mechanism–outcome configurations, to identify additional context–mechanism–outcome configurations and to identify additional literature and/or relevant concepts. In phase 2 we reviewed and synthesised relevant published and unpublished empirical evidence and tested the programme theories using evidence from a larger set of empirical studies. Results: We developed a single logic model structured around three key mechanisms: (1) personalisation, (2) systematisation and (3) evidence implementation. Personalisation: STOPP/START-based interventions are based on shared decision-making, taking into account patient preferences, experiences and expectations (mechanisms), leading to increased patient awareness, adherence, satisfaction, empowerment and quality of life (outcomes). Systematisation: STOPP/START tools provide a standardised/systematic approach for medication reviews (mechanisms), leading to changes in professional and organisational culture and burden/costs (outcomes). Evidence implementation: delivery of STOPP/START-based interventions is based on the implementation of best evidence (mechanisms), reducing adverse outcomes through appropriate prescribing/deprescribing (outcomes). For theory testing, we identified 40 studies of the impact of STOPP/START-based interventions in hospital settings, nursing homes, primary care and community pharmacies. Most of the interventions used multiple mechanisms. We found support for the impact of the personalisation and evidence implementation mechanisms on selected outcome variables, but similar impact was achieved by interventions not relying on these mechanisms. We also observed that the impact of interventions was linked to the proximity of the selected outcomes to the intervention in the logic model, resulting in a clearer benefit for appropriateness of prescribing, adverse drug events and prescription costs. Limitations: None of the available studies had been explicitly designed for evaluating underlying causal mechanisms, and qualitative information was sparse. Conclusions: No particular configuration of the interventions is associated with a greater likelihood of improved outcomes in given settings. Study registration: This study is registered as PROSPERO CRD42018110795. Funding: This project was funded by the National Institute for Health Research (NIHR) Health Services and Delivery Research programme and will be published in full in Health Services and Delivery Research; Vol. 9, No. 23. See the NIHR Journals Library website for further project information.https://doi.org/10.3310/hsdr09230medication reviewmedication reconciliationinappropriate medicationolder adults
spellingShingle Jaheeda Gangannagaripalli
Ian Porter
Antoinette Davey
Ignacio Ricci Cabello
Joanne Greenhalgh
Rob Anderson
Simon Briscoe
Carmel Hughes
Rupert Payne
Emma Cockcroft
Jim Harris
Charlotte Bramwell
Jose M Valderas
STOPP/START interventions to improve medicines management for people aged 65 years and over: a realist synthesis
Health Services and Delivery Research
medication review
medication reconciliation
inappropriate medication
older adults
title STOPP/START interventions to improve medicines management for people aged 65 years and over: a realist synthesis
title_full STOPP/START interventions to improve medicines management for people aged 65 years and over: a realist synthesis
title_fullStr STOPP/START interventions to improve medicines management for people aged 65 years and over: a realist synthesis
title_full_unstemmed STOPP/START interventions to improve medicines management for people aged 65 years and over: a realist synthesis
title_short STOPP/START interventions to improve medicines management for people aged 65 years and over: a realist synthesis
title_sort stopp start interventions to improve medicines management for people aged 65 years and over a realist synthesis
topic medication review
medication reconciliation
inappropriate medication
older adults
url https://doi.org/10.3310/hsdr09230
work_keys_str_mv AT jaheedagangannagaripalli stoppstartinterventionstoimprovemedicinesmanagementforpeopleaged65yearsandoverarealistsynthesis
AT ianporter stoppstartinterventionstoimprovemedicinesmanagementforpeopleaged65yearsandoverarealistsynthesis
AT antoinettedavey stoppstartinterventionstoimprovemedicinesmanagementforpeopleaged65yearsandoverarealistsynthesis
AT ignacioriccicabello stoppstartinterventionstoimprovemedicinesmanagementforpeopleaged65yearsandoverarealistsynthesis
AT joannegreenhalgh stoppstartinterventionstoimprovemedicinesmanagementforpeopleaged65yearsandoverarealistsynthesis
AT robanderson stoppstartinterventionstoimprovemedicinesmanagementforpeopleaged65yearsandoverarealistsynthesis
AT simonbriscoe stoppstartinterventionstoimprovemedicinesmanagementforpeopleaged65yearsandoverarealistsynthesis
AT carmelhughes stoppstartinterventionstoimprovemedicinesmanagementforpeopleaged65yearsandoverarealistsynthesis
AT rupertpayne stoppstartinterventionstoimprovemedicinesmanagementforpeopleaged65yearsandoverarealistsynthesis
AT emmacockcroft stoppstartinterventionstoimprovemedicinesmanagementforpeopleaged65yearsandoverarealistsynthesis
AT jimharris stoppstartinterventionstoimprovemedicinesmanagementforpeopleaged65yearsandoverarealistsynthesis
AT charlottebramwell stoppstartinterventionstoimprovemedicinesmanagementforpeopleaged65yearsandoverarealistsynthesis
AT josemvalderas stoppstartinterventionstoimprovemedicinesmanagementforpeopleaged65yearsandoverarealistsynthesis